126 results
8-K
EX-3.1
AUPH
Aurinia Pharmaceuticals Inc.
12 Sep 24
Aurinia Announces Board Restructuring
4:08pm
such other information as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as an independent
8-K
AUPH
Aurinia Pharmaceuticals Inc.
14 Jun 24
Submission of Matters to a Vote of Security Holders
5:25pm
of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc.
4 Jun 24
Additional proxy soliciting materials
5:25pm
Independent Proxy Advisory Service The Company recommends that shareholders review the recent report from Glass Lewis, a leading independent proxy
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc.
3 May 24
Additional proxy soliciting materials
4:11pm
PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm until the close of the 2025 annual general meeting of shareholders or until
8-K
5xmrwv4aum
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
PX14A6G
ih4q0kpdv607j2fr
1 Jun 23
Letter to shareholders
2:01pm
S-8
smq3bf2ad5ens7 tij
26 May 23
Registration of securities for employees
4:39pm
8-K
nkb 6dya8t8
17 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
PX14A6G
8nns366
11 May 23
Letter to shareholders
11:34am
PX14A6G
oqzx bywez
5 May 23
Letter to shareholders
11:17am
PX14A6G
8e8stdd ilg
3 May 23
Letter to shareholders
2:53pm